Table 3 Treatment characteristics in our CCUP patient cohort
Treatment | n/median | % |
|---|---|---|
Radiotherapy | ||
definitive | 21 | 36.2 |
adjuvant | 35 | 60.3 |
palliative | 2 | 3.4 |
Completion radiotherapy | ||
no | 4 | 6.9 |
yes | 52 | 89.7 |
unknown | 2 | 3.4 |
Radiotherapy dose (median, range) | ||
Total dose (including boost) | 60.0 Gy (18.0–72.0) | |
Single radiation dose | ||
1.7 Gy | 1 | 1.7 |
1.8 Gy | 3 | 5.2 |
2 Gy | 52 | 89.7 |
3 Gy | 2 | 3.4 |
Boost,n = 48 | ||
integrated | 4 | 8.3 |
sequential | 44 | 91.7 |
Simultaneous chemotherapy | ||
no | 18 | 31.0 |
yes | 40 | 69.0 |
Chemotherapy,n = 40 | ||
cisplatin | 27 | 67.5 |
cisplatin/5-fluorouracil | 4 | 10.0 |
cetuximab | 1 | 2.5 |
carboplatin | 5 | 12.5 |
others1 | 3 | 5.0 |
Completion chemotherapy, n = 40 | ||
no | 6 | 15.0 |
yes | 26 | 65.0 |
unknown | 8 | 20.0 |